The Rising Roles of Exosomes in the Tumor Microenvironment Reprogramming and Cancer Immunotherapy

Overview

Journal MedComm (2020)

Specialty Health Services

Date 2024 Apr 8

PMID 38585234

Authors

Yu Wu

Wenyan Han

Hairong Dong

Xiaofeng Liu

Xiulan Su

Affiliations

Soon will be listed here.

Abstract

Exosomes are indispensable for intercellular communications. Tumor microenvironment (TME) is the living environment of tumor cells, which is composed of various components, including immune cells. Based on TME, immunotherapy has been recently developed for eradicating cancer cells by reactivating antitumor effect of immune cells. The communications between tumor cells and TME are crucial for tumor development, metastasis, and drug resistance. Exosomes play an important role in mediating these communications and regulating the reprogramming of TME, which affects the sensitivity of immunotherapy. Therefore, it is imperative to investigate the role of exosomes in TME reprogramming and the impact of exosomes on immunotherapy. Here, we review the communication role of exosomes in regulating TME remodeling and the efficacy of immunotherapy, as well as summarize the underlying mechanisms. Furthermore, we also introduce the potential application of the artificially modified exosomes as the delivery systems of antitumor drugs. Further efforts in this field will provide new insights on the roles of exosomes in intercellular communications of TME and cancer progression, thus helping us to uncover effective strategies for cancer treatment.

Citing Articles

Exosomes: a double-edged sword in cancer immunotherapy.

Chen J, Hu S, Liu J, Jiang H, Wang S, Yang Z MedComm (2020). 2025; 6(3):e70095.

PMID: 39968497 PMC: 11831209. DOI: 10.1002/mco2.70095.

Extracellular vesicles in tumor immunity: mechanisms and novel insights.

Kuang L, Wu L, Li Y Mol Cancer. 2025; 24(1):45.

PMID: 39953480 PMC: 11829561. DOI: 10.1186/s12943-025-02233-w.

Exosomal ncRNAs in reproductive cancers†.

Kowalczyk A, Wrzecinska M, Galeska E, Czerniawska-Piatkowska E, Camina M, Araujo J Biol Reprod. 2024; 112(2):225-244.

PMID: 39561105 PMC: 11833474. DOI: 10.1093/biolre/ioae170.

Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment.

Vitorakis N, Gargalionis A, Papavassiliou K, Adamopoulos C, Papavassiliou A Cancers (Basel). 2024; 16(16).

PMID: 39199647 PMC: 11352254. DOI: 10.3390/cancers16162876.

Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles.

Barathan M, Zulpa A, Ng S, Lokanathan Y, Ng M, Law J Int J Mol Sci. 2024; 25(13).

PMID: 39000577 PMC: 11242358. DOI: 10.3390/ijms25137470.

References

Harari A, Graciotti M, Bassani-Sternberg M, Kandalaft L . Antitumour dendritic cell vaccination in a priming and boosting approach. Nat Rev Drug Discov. 2020; 19(9):635-652. DOI: 10.1038/s41573-020-0074-8. View

Spranger S, Dai D, Horton B, Gajewski T . Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. Cancer Cell. 2017; 31(5):711-723.e4. PMC: 5650691. DOI: 10.1016/j.ccell.2017.04.003. View

Hu S, Ma J, Su C, Chen Y, Shu Y, Qi Z . Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis. Acta Biomater. 2021; 135:567-581. DOI: 10.1016/j.actbio.2021.09.003. View

Du Z, Huang Z, Chen X, Jiang G, Peng Y, Feng W . Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation. Exp Hematol Oncol. 2022; 11(1):36. PMC: 9172178. DOI: 10.1186/s40164-022-00289-8. View

Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y . Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023; 22(1):55. PMC: 10024440. DOI: 10.1186/s12943-023-01759-1. View

Hinshaw D, Shevde L . The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019; 79(18):4557-4566. PMC: 6744958. DOI: 10.1158/0008-5472.CAN-18-3962. View

Tanaka A, Sakaguchi S . Targeting Treg cells in cancer immunotherapy. Eur J Immunol. 2019; 49(8):1140-1146. DOI: 10.1002/eji.201847659. View

Gu J, Qian H, Shen L, Zhang X, Zhu W, Huang L . Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-β/Smad pathway. PLoS One. 2013; 7(12):e52465. PMC: 3527492. DOI: 10.1371/journal.pone.0052465. View

Pan Y, Yu Y, Wang X, Zhang T . Corrigendum: Tumor-Associated Macrophages in Tumor Immunity. Front Immunol. 2021; 12:775758. PMC: 8704129. DOI: 10.3389/fimmu.2021.775758. View

10.

Nakano T, Chen I, Wang C, Chen P, Tseng H, Huang K . Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence. Am J Transplant. 2019; 19(12):3250-3262. DOI: 10.1111/ajt.15490. View

11.

Xu G, Zhang B, Ye J, Cao S, Shi J, Zhao Y . Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression. Int J Biol Sci. 2019; 15(11):2320-2329. PMC: 6775321. DOI: 10.7150/ijbs.33750. View

12.

Fukumura D, Kloepper J, Amoozgar Z, Duda D, Jain R . Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018; 15(5):325-340. PMC: 5921900. DOI: 10.1038/nrclinonc.2018.29. View

13.

Szajnik M, Czystowska M, Szczepanski M, Mandapathil M, Whiteside T . Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010; 5(7):e11469. PMC: 2908536. DOI: 10.1371/journal.pone.0011469. View

14.

Xiang X, Niu Y, Wang Z, Ye L, Peng W, Zhou Q . Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment. Cytokine Growth Factor Rev. 2022; 67:35-48. DOI: 10.1016/j.cytogfr.2022.07.006. View

15.

Xu L, Xie J, Shen J, Ying M, Chen X . Neuron-derived exosomes mediate sevoflurane-induced neurotoxicity in neonatal mice via transferring lncRNA Gas5 and promoting M1 polarization of microglia. Acta Pharmacol Sin. 2023; 45(2):298-311. PMC: 10789735. DOI: 10.1038/s41401-023-01173-9. View

16.

He Q, Ye A, Ye W, Liao X, Qin G, Xu Y . Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis. 2021; 12(6):576. PMC: 8178321. DOI: 10.1038/s41419-021-03803-8. View

17.

Liu M, Zhou J, Liu X, Feng Y, Yang W, Wu F . Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma. Gut. 2019; 69(2):365-379. DOI: 10.1136/gutjnl-2018-317257. View

18.

Deborde S, Gusain L, Powers A, Marcadis A, Yu Y, Chen C . Reprogrammed Schwann Cells Organize into Dynamic Tracks that Promote Pancreatic Cancer Invasion. Cancer Discov. 2022; 12(10):2454-2473. PMC: 9533012. DOI: 10.1158/2159-8290.CD-21-1690. View

19.

Fan J, Zhou Z, Luo Y, Luo Q, Chen S, Zhao J . Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway. Neoplasia. 2021; 23(7):692-703. PMC: 8233173. DOI: 10.1016/j.neo.2021.05.004. View

20.

Yang L, Luo Q, Lu L, Zhu W, Sun H, Wei R . Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 2020; 13(1):3. PMC: 6945602. DOI: 10.1186/s13045-019-0836-0. View